clinical trial

Roche culls ph. 3 Spark gene therapy in hemophilia

After the elimination of a gene therapy study last week, Roche confirmed that it’s axing a hemophilia candidate from its buyout of Spark Therapeutics.

Fraiser Kansteiner Dec 16, 2024 12:24pm

FDA chides Applied Therapeutics' trial conduct in warning letter

Dec 4, 2024 11:21am

Sanofi will deploy new AI tool in late-stage MS trials

Nov 13, 2024 7:40am

Novartis channels Gargamel, terminating midphase SMURF1 trial

Oct 14, 2024 9:14am

New AI-powered program offers clinical trial insurance

Jul 24, 2024 10:00am

Insmed's shares double as lung disease med powers past phase 3

May 28, 2024 10:32am